The Cytel Blog: Perspectives on Enquiry & Evidence

Ten years ago, a seminal paper published by Cytel Founder Cyrus Mehta, introduced the Promising Zone Design to..

Methods involving Group Sequential Designs is one of the earliest deviations from a traditional two-arm clinical trial..

Cytel is conducting a webinar series that introduces biostatisticians to some of the more commonly used complex..

In this blog, we speak with Christopher Jennison, Professor of Statistics at the University of Bath, UK. Professor..

Adaptive sample size re-estimation designs are an important part of the statistician's toolkit. In this first in a..

In the 2010 draft FDA ‘Guidance for Industry on Adaptive Design Clinical Trials for Drugs and Biologics',  the agency..

  At the recent JSM in Chicago, Cytel’s Sam Hsaio and Lingyun Liu alongside Genentech's Romeo Maciuca, presented a..

In order for adaptive designs to reach their potential, it’s critical that knowledge is effectively dissemirnated..

   Francois Beckers, Global Head of Biostatistics & Epidemiology at Merck KGaA joined us at the East User Group Meeting..